Sun Hwayeon, Park Sangmin, Mok Jiye, Seo Jeonghyun, Lee Nicole Dain, Yoo Byungwook
Microbiome R&D Center, Pharmsville, Co., Ltd., Seoul 07793, Republic of Korea.
School of Medicine, Georgetown University, Washington, DC 20007, USA.
Foods. 2024 Oct 16;13(20):3285. doi: 10.3390/foods13203285.
Alcohol-related hangovers impact both physical and mental wellness, largely due to acetaldehyde levels produced through alcohol metabolism. The present study investigated the efficacy and safety of the Wilac L probiotic complex ( WiKim0168 and WiKim0172 isolated from kimchi) in improving hangovers post-alcohol consumption. This study was conducted as a randomized, double-blind, crossover placebo-controlled clinical trial from August 2023 to February 2024. Subjects ( = 26) were randomized into six test groups consuming three products, the Wilac L probiotic complex, Wilac L35 (Wilac L probiotic complex with Nakai), or placebo, in different orders with crossover after a wash-out interval of 7-10 days. Blood alcohol and acetaldehyde concentrations were measured 0, 0.25, 0.5, 1, 2, 4, 6, and 15 h after alcohol consumption. The blood acetaldehyde levels measured with Wilac L probiotic complex supplementation were significantly lower than the control at 0.25 ( = 0.0381), 0.5 ( = 0.0498), and 1 h ( = 0.0260) post-consumption. The blood acetaldehyde levels after Wilac L35 consumption compared to the control are significant at 0.25 ( = 0.0115), 0.5 ( = 0.0054), 1 ( = 0.0285), 2 ( = 0.0113), and 6 h ( = 0.0287) post-consumption. No significant adverse events were reported. The Wilac L probiotic complex is associated with decreased blood acetaldehyde levels and improved subjective hangover symptoms.
与酒精相关的宿醉会影响身心健康,这主要是由于酒精代谢产生的乙醛水平所致。本研究调查了Wilac L益生菌复合物(从泡菜中分离出的WiKim0168和WiKim0172)在改善饮酒后宿醉方面的功效和安全性。本研究于2023年8月至2024年2月作为一项随机、双盲、交叉安慰剂对照临床试验进行。受试者(n = 26)被随机分为六个测试组,以不同顺序服用三种产品,即Wilac L益生菌复合物、Wilac L35(含中井的Wilac L益生菌复合物)或安慰剂,在7 - 10天的洗脱期后进行交叉。在饮酒后0、0.25、0.5、1、2、4、6和15小时测量血液中的酒精和乙醛浓度。补充Wilac L益生菌复合物后测得的血液乙醛水平在饮酒后0.25小时(p = 0.0381)、0.5小时(p = 0.0498)和1小时(p = 0.0260)显著低于对照组。与对照组相比,服用Wilac L35后血液乙醛水平在饮酒后0.25小时(p = 0.0115)、0.5小时(p = 0.0054)、1小时(p = 0.0285)、2小时(p = 0.0113)和6小时(p = 0.0287)有显著差异。未报告重大不良事件。Wilac L益生菌复合物与血液乙醛水平降低和主观宿醉症状改善有关。